NEW YORK STOCK EXCHANGE, INC. · HIMS
-0.70% · -$0.2300 · Vol 15.1M
Market closed · last close 4:00 PM ET · price as of 19:57:28 ET
Hims & Hers Health Inc

Hims & Hers Health Inc

Health Care
$32.47

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is HIMS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Hims & Hers Health Inc
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Listed since
2021
Employees
2K
Country
US

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$33.41
Day high
$33.45
Day low
$30.29
Previous close
$32.70
52W high
$35.47
-8.46% from high
52W low
$27.05
64% of range
Market cap
$7.6B
P/E
58.98×
EPS
$0.0300
Shares out
231.5M
Volume
15.1M
VWAP
$31.47
Price history computed in-house
1W
-8.46%
SMA 50 $31.59 · above
SMA 200 $31.59 · above
52W position 64%
Veridion warehouse edge

Warehouse intelligence for HIMS.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

HIMS insider activity

Hims & Hers Health Inc

Score
Coverage building
Pressure
Net selling
Filings
59
Buys / sells
15 / 44
Net value
-$49.1M
Insiders
9
Named filers
OO
Okupe Oluyemi
Insider
Leadership
CH
Carroll Patrick Harrison
Insider
Leadership
WB
WELLS DAVID B
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net selling: -$49.1M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-232026-06-22Okupe OluyemiInsidersell$34.0318,197284,321$619KSEC Form 4
2026-06-232026-06-22Okupe OluyemiInsiderbuy$5.016,376302,518$32KSEC Form 4
2026-06-232026-06-18Carroll Patrick HarrisonInsidersell$35.0023,726181,861$830KSEC Form 4
2026-05-262026-05-26WELLS DAVID BInsiderbuy$24.2348,400224,417$1.2MSEC Form 4
2026-05-192026-05-18Okupe OluyemiInsidersell$23.647,950262,954$188KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 54 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

HIMS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HIMS in this window.
Lobbying spend

HIMS lobbying filings, year to date.

Registered lobbying filings matched to Hims & Hers Health Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HIMS in this window.
Latest news · HIMS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for HIMS.
Options
Sovereign unlock shows live options positioning for HIMS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.